跳至主要内容
临床试验/EUCTR2011-001573-10-BE
EUCTR2011-001573-10-BE进行中(未招募)不适用

optimization of doses of broad spectrum B-lactames (ceftazidim and meropenem) and vancomycin in septic patient traeted with chronic hemodialysis.

Hôpital Erasme0 个研究点开始时间: 2011年10月4日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -patient with a chronic renal failure and aligo-anuric in hemodialysis, hospitalised or not.
  • -intravenous antibiotics traet gived to treat an infection.
  • -patient receiving a combination of ceftazidim/vancomicyn or meropenem/vancomycin may be included.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • -severe sepsis and sepsis shock
  • -doses higher than recommanded antibiotics (traetment of meningitis...)
  • -pregnant woman
  • -age < 18y
  • -antibiotics prophylaxis
  • -obese (BMI > 30 kg/m²) or cachexic (BMI < 15 kg/m²) patient

研究者

相似试验

进行中(未招募)
1 期
what are the optimal doses of broad spectrum B-lactams to administer to obese patients if infected?any patient with a BMI >= 30kg/m² and has a simple or severe infection.MedDRA version: 14.0Level: PTClassification code 10060945Term: Bacterial infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2011-004239-29-BEHopital Erasme120
招募中
不适用
Does guideline-based dosing of beta lactam antibiotics and vancomycin achieve the target drug concentrations more than therapeutic drug monitoring-based dosing in critically ill patients? (GUIDE TRIAL)Sepsis
ACTRN12619000693123Paul Williams150
进行中(未招募)
1 期
Dose individualization of beta-lactam and fluoroquinolone antibiotics in intensive care unit patientsICU patients with infection
EUCTR2017-004677-14-NLErasmus MC250
尚未招募
不适用
Dose individualization of Beta-lactam and fluoroquinolone antibiotics in ICU patients: to TDM or not to TDM and the effects on OutcomeIntensive care, Antibiotics, Pharmacodynamics, Pharmacokinetics
NL-OMON21680Erasmus MC250
进行中(未招募)
1 期
Pharmacokinetics of small spectcrum beta-lactam antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) on intensive care.Patients who are hospitalised on the Intensive Care Unit, and who are treated with Amoxicillin/Clavulanic acid or Cefuroxime, because of an infection.MedDRA version: 14.1Level: LLTClassification code 10053349Term: Pharmacokinetic studySystem Organ Class: 10022891 - Investigations
EUCTR2011-006107-35-BEGhent University Hospital37